QuantiFERON®-CMV

    Latest News

     ÃֽŠ³í¹®À» ¼Ò°³ÇØ µå¸³´Ï´Ù.

      [ New Publications ]

¡°How do I know which of my transplant patients are at risk of CMV disease?

 

First Author

Title

Journal

Publication Date

PubMed link

Updated date

Lúcia M

 Human CMV-specific T-cell responses in kidney transplantation;  toward changing current risk- stratification paradigm.

Transpl Int

2014 Mar

Link

2014.4.30

Abate D

 Comparison of cytomegalovirus (CMV) enzyme-linked  immunosorbent spot and CMV immunosorbent spot and CMV quantiferon gamma interferon-  releasing assays in assessing risk of CMV infection in kidney  transplant recipients.

J Clin Microbiol

2013 Aug

Link

2014.4.30

Tey SK

Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.

PLoS One

2013 Oct

Link

2014.5.13

Manuel O

Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.

Clin Infect Dis

2013 Mar

Link

2014.5.13

Lochmanova A

Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.

Transplant Proc

2010

Link

2014.5.13

Kumar D

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients

Am J Transplant

2009

Link

2014.5.13

Walker S

Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.

Transpl Infect Dis

2007

Link

2014.5.13